A 2024 survey of eCOA professionals at sponsor organizations revealed that 50% of respondents identified eCOA Data Change ...
MALVERN, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...
"At Medimaps, we understand the growing pressures faced by radiology departments. With the next generation of TBS Osteo, ...
TBS Osteo’s next generation expands fracture risk assessment ... and direct patient engagement. The science behind our cutting-edge imaging applications and clinical evidence forms the core ...
A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...
From consumer products to clinical ... while some patients may be able to participate in a study during the week, others may need to participate on weekends. All forms of engagement help, but ...
Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...
In its drive to transform health care in the Tampa Bay region and beyond, Tampa General Hospital (TGH) has reached another milestone — a prestigious stamp of approval by the American Society of ...
A £1.65 million treatment has been approved for use for some NHS patients, offering hope of a cure to those with an inherited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback